NewAmsterdam Pharma Company N.V. Share Price BOERSE MUENCHEN
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.3 EUR | 0.00% |
|
+7.65% | 0.00% |
Sales 2024 * | 86.38L 92.51L 77Cr | Sales 2025 * | 63.11L 67.59L 56Cr | Capitalization | 165.37Cr 177.11Cr 15TCr |
---|---|---|---|---|---|
Net income 2024 * | -21Cr -22Cr -1.88TCr | Net income 2025 * | -14Cr -15Cr -1.24TCr | EV / Sales 2024 * | 191 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 262 x |
P/E ratio 2024 * |
-7.86
x | P/E ratio 2025 * |
-12.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 week | +15.09% | ||
Current month | +7.02% | ||
1 month | +5.17% | ||
3 months | -12.02% |
![Extreme 15.9](/images/extremecours_fleche.png)
![Extreme 15.9](/images/extremecours_fleche.png)
Date | Price | Change |
---|---|---|
25/24/25 | 18.3 | 0.00% |
24/24/24 | 18.3 | +8.93% |
21/24/21 | 16.8 | +3.70% |
20/24/20 | 16.2 | +0.62% |
19/24/19 | 16.1 | +1.26% |
Real-time BOERSE MUENCHEN, June 26, 2024 at 01:13 am IST
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.45% | 12TCr | |
+21.96% | 11TCr | |
+23.73% | 2.59TCr | |
-20.05% | 2.09TCr | |
-16.28% | 1.68TCr | |
-16.52% | 1.65TCr | |
-44.35% | 1.56TCr | |
+63.91% | 1.55TCr | |
+2.52% | 1.34TCr |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock